DK0558529T3 - Farmaceutisk præparat til behandling af forlænget koagulationstid - Google Patents
Farmaceutisk præparat til behandling af forlænget koagulationstidInfo
- Publication number
- DK0558529T3 DK0558529T3 DK91919614.7T DK91919614T DK0558529T3 DK 0558529 T3 DK0558529 T3 DK 0558529T3 DK 91919614 T DK91919614 T DK 91919614T DK 0558529 T3 DK0558529 T3 DK 0558529T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- pharmaceutical preparation
- clotting time
- prolonged clotting
- prolonged
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK261490A DK261490D0 (da) | 1990-10-31 | 1990-10-31 | New pharmaceutical compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0558529T3 true DK0558529T3 (da) | 1996-06-03 |
Family
ID=8113744
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK261490A DK261490D0 (da) | 1990-10-31 | 1990-10-31 | New pharmaceutical compound |
DK91919614.7T DK0558529T3 (da) | 1990-10-31 | 1991-10-18 | Farmaceutisk præparat til behandling af forlænget koagulationstid |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK261490A DK261490D0 (da) | 1990-10-31 | 1990-10-31 | New pharmaceutical compound |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0558529B1 (da) |
JP (1) | JPH06502171A (da) |
AT (1) | ATE132757T1 (da) |
AU (1) | AU657926B2 (da) |
CA (1) | CA2095356A1 (da) |
CZ (1) | CZ282497B6 (da) |
DE (1) | DE69116380T2 (da) |
DK (2) | DK261490D0 (da) |
ES (1) | ES2083597T3 (da) |
GR (1) | GR3019514T3 (da) |
HU (1) | HUT64236A (da) |
RU (1) | RU2127600C1 (da) |
SK (1) | SK282516B6 (da) |
UA (1) | UA35567C2 (da) |
WO (1) | WO1992007584A1 (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030171292A1 (en) | 1992-06-01 | 2003-09-11 | Creasey Abla A. | Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
US6063764A (en) * | 1992-06-01 | 2000-05-16 | Washington University & Chiron Corp. | Method for using lipoprotein associated coagulation inhibitor to treat sepsis |
GB2268909B (en) * | 1992-07-21 | 1995-10-25 | Profy International Corp | Unitary loose sheet binder |
US7015194B2 (en) | 2000-05-10 | 2006-03-21 | Novo Nordisk A/S | Pharmaceutical composition comprising factor VIIa and anti-TFPI |
BR0110659A (pt) * | 2000-05-10 | 2003-02-11 | Novo Nordisk As | Composição farmacêutica, kit, uso de um fator viia em combinação com um fator, xiii, e, métodos para intensificação da formação de coágulo de fibrina em um indivìduo e para tratar de episódios de hemorragia em um indivìduo |
MXPA04003547A (es) | 2001-10-15 | 2004-07-22 | Chiron Corp | Tratamiento de sepsis mediante administracion de dosis bajas de inhibidor de via factor de tejido. |
US20080161425A1 (en) * | 2005-07-29 | 2008-07-03 | Universiteit Van Maastricht | Regulation of Tissue Factor Activity by Protein S and Tissue Factor Pathway Inhibitor |
RU2011101969A (ru) | 2008-06-30 | 2012-08-10 | Ново Нордиск А/С (DK) | Антитела к человеческому интерлейкину-20 |
UA112050C2 (uk) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi) |
BR122021014783B1 (pt) * | 2008-12-19 | 2023-03-14 | Baxalta GmbH | Peptídeo que se liga a tfpi, uso do peptídeo, composição farmacêutica e método para purificação de tfpi |
RU2562114C2 (ru) * | 2008-12-22 | 2015-09-10 | Ново Нордиск А/С | Антитела против ингибитора метаболического пути тканевого фактора |
US8454956B2 (en) | 2009-08-31 | 2013-06-04 | National Cheng Kung University | Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies |
CA2789061A1 (en) | 2010-02-26 | 2011-09-01 | Henrik Parshad | Stable antibody containing compositions |
WO2011109452A1 (en) | 2010-03-01 | 2011-09-09 | Bayer Healthcare Llc | Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) |
CN103025345B (zh) | 2010-03-19 | 2016-01-20 | 巴克斯特国际公司 | Tfpi抑制剂及使用方法 |
CA2800188A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
US9228022B2 (en) | 2010-06-30 | 2016-01-05 | Novo Nordisk A/S | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
US9260518B2 (en) | 2010-06-30 | 2016-02-16 | Novo Nordisk A/S | Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
AU2013235741C1 (en) | 2012-03-21 | 2017-12-21 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
WO2014015133A1 (en) | 2012-07-19 | 2014-01-23 | National Cheng Kung University | Treatment of osteoarthritis using il-20 antagonists |
US8603470B1 (en) | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
US8852588B2 (en) | 2012-08-07 | 2014-10-07 | National Cheng Kung University | Treating allergic airway disorders using anti-IL-20 receptor antibodies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87172A (en) * | 1987-07-23 | 1994-12-29 | Univ Washington | A method of inhibiting the isolation of a purer tissue factor |
IL87171A (en) * | 1987-11-23 | 1995-08-31 | Monsanto Co | ANDC of human tissue factor inhibitor |
EP0409858B1 (en) * | 1988-03-17 | 1993-12-08 | Novo Nordisk A/S | Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them |
DK148890D0 (da) * | 1990-06-19 | 1990-06-19 | Novo Nordisk As | Farmaceutisk praeparat |
-
1990
- 1990-10-31 DK DK261490A patent/DK261490D0/da not_active Application Discontinuation
-
1991
- 1991-10-18 AU AU88711/91A patent/AU657926B2/en not_active Ceased
- 1991-10-18 DK DK91919614.7T patent/DK0558529T3/da active
- 1991-10-18 ES ES91919614T patent/ES2083597T3/es not_active Expired - Lifetime
- 1991-10-18 UA UA93004415A patent/UA35567C2/uk unknown
- 1991-10-18 RU RU93032613A patent/RU2127600C1/ru active
- 1991-10-18 SK SK428-93A patent/SK282516B6/sk unknown
- 1991-10-18 EP EP91919614A patent/EP0558529B1/en not_active Expired - Lifetime
- 1991-10-18 CZ CZ93786A patent/CZ282497B6/cs not_active IP Right Cessation
- 1991-10-18 JP JP3518142A patent/JPH06502171A/ja active Pending
- 1991-10-18 CA CA002095356A patent/CA2095356A1/en not_active Abandoned
- 1991-10-18 DE DE69116380T patent/DE69116380T2/de not_active Expired - Fee Related
- 1991-10-18 WO PCT/DK1991/000317 patent/WO1992007584A1/en active IP Right Grant
- 1991-10-18 HU HU9301253A patent/HUT64236A/hu unknown
- 1991-10-18 AT AT91919614T patent/ATE132757T1/de not_active IP Right Cessation
-
1996
- 1996-04-02 GR GR960400902T patent/GR3019514T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2083597T3 (es) | 1996-04-16 |
RU2127600C1 (ru) | 1999-03-20 |
DE69116380D1 (de) | 1996-02-22 |
EP0558529A1 (en) | 1993-09-08 |
UA35567C2 (uk) | 2001-04-16 |
SK42893A3 (en) | 1993-09-09 |
AU657926B2 (en) | 1995-03-30 |
ATE132757T1 (de) | 1996-01-15 |
GR3019514T3 (en) | 1996-07-31 |
AU8871191A (en) | 1992-05-26 |
DK261490D0 (da) | 1990-10-31 |
CZ282497B6 (cs) | 1997-07-16 |
HU9301253D0 (en) | 1993-07-28 |
WO1992007584A1 (en) | 1992-05-14 |
CA2095356A1 (en) | 1992-05-01 |
DE69116380T2 (de) | 1996-07-11 |
EP0558529B1 (en) | 1996-01-10 |
SK282516B6 (sk) | 2002-10-08 |
HUT64236A (en) | 1993-12-28 |
CZ78693A3 (en) | 1993-12-15 |
JPH06502171A (ja) | 1994-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0558529T3 (da) | Farmaceutisk præparat til behandling af forlænget koagulationstid | |
EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
NO944997D0 (no) | Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte | |
RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
PT1052905E (pt) | Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol | |
DK0514452T3 (da) | Anvendelse af insulin-sensibiliserende midler til behandling af hypertension | |
NO893637L (no) | Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer. | |
KR890011606A (ko) | 항응고제 | |
ATE174221T1 (de) | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten | |
EP1065200A4 (en) | Aminoisoquinoline DERIVATIVES | |
ATE87476T1 (de) | Fluessige orale formulierung. | |
BR9809478A (pt) | Uso de um oligossacarìdeo sintético, processos para prevenção de coagulação sanguìnea em um mamìfero e para prevenção de coagulação sanguìnea e um circuito sanguìneo extracorpóreo, e, composição farmacêutica adaptada para prevenir coagulação sanguìnea em um circuito sanguìneo extracorpóreo | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
DK301190D0 (da) | Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker | |
DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
DK630088D0 (da) | Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel | |
ATE319455T1 (de) | Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten | |
ATE222103T1 (de) | Inklusionskomplexe in waessriger loesung | |
DE69113437D1 (de) | Therapeutische Mittel für diabetisches Gangrän. | |
SE8802040D0 (sv) | New use | |
DE3876425D1 (de) | Gesteuerte verabreichung eines heilmittels an blut. | |
DE69831981D1 (de) | Wässerige Lösung zur Behandlung von Enteroclysis bei hepatischer Enzephalopathie | |
DE3772047D1 (de) | Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten. | |
BR0015424A (pt) | Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco | |
DK475989A (da) | Anvendelse af pyrazolopyridinderivater eller fysiologisk acceptable salte deraf i laegmidler til behandling af epilepsi |